Five Prime Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Five Prime Therapeutics, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$10.62 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-08
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$10.62M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$27.46M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$27.70M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$29.09M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$112.18M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$79.75M, a 127.59% decline from fiscal 2015.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $289.10M, a 1793.86% increase from fiscal 2014.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $15.27M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$10.62M 10-Q · filed 2018-05-08 | -$38.09M derived: sum of 2 quarters · filed 2018-05-08 | -$65.79M derived: sum of 3 quarters · filed 2018-05-08 | -$94.88M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | -$27.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$55.17M derived: sum of 2 quarters · filed 2018-02-27 | -$84.25M derived: sum of 3 quarters · filed 2018-02-27 | -$112.18M 10-K · filed 2018-02-27 |
| 2017-09-30 | -$27.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$56.79M derived: sum of 2 quarters · filed 2017-11-06 | -$84.72M 10-Q · filed 2017-11-06 | -$99.64M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | -$29.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$57.02M 10-Q · filed 2017-08-08 | -$71.94M derived: sum of 3 quarters · filed 2018-05-08 | -$87.60M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | -$27.93M 10-Q · filed 2018-05-08 | -$42.85M derived: sum of 2 quarters · filed 2018-05-08 | -$58.51M derived: sum of 3 quarters · filed 2018-05-08 | -$73.57M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$14.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$30.59M derived: sum of 2 quarters · filed 2018-02-27 | -$45.64M derived: sum of 3 quarters · filed 2018-02-27 | -$79.75M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$15.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$30.72M derived: sum of 2 quarters · filed 2017-11-06 | -$64.83M 10-Q · filed 2017-11-06 | $268.76M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$15.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$49.17M 10-Q · filed 2017-08-08 | $284.42M derived: sum of 3 quarters · filed 2018-02-27 | $260.14M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$34.11M 10-Q · filed 2017-05-05 | $299.48M derived: sum of 2 quarters · filed 2018-02-27 | $275.20M derived: sum of 3 quarters · filed 2018-02-27 | $265.54M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $333.59M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $309.31M derived: sum of 2 quarters · filed 2018-02-27 | $299.65M derived: sum of 3 quarters · filed 2018-02-27 | $289.10M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$24.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$33.94M derived: sum of 2 quarters · filed 2016-11-04 | -$44.49M 10-Q · filed 2016-11-04 | -$25.79M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | -$9.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$20.21M 10-Q · filed 2016-08-05 | -$1.51M derived: sum of 3 quarters · filed 2017-02-24 | -$11.40M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | -$10.55M 10-Q · filed 2016-05-06 | $8.15M derived: sum of 2 quarters · filed 2017-02-24 | -$1.75M derived: sum of 3 quarters · filed 2017-02-24 | $10.30M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $18.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $8.81M derived: sum of 2 quarters · filed 2017-02-24 | $20.86M derived: sum of 3 quarters · filed 2017-02-24 | $15.27M 10-K · filed 2017-02-24 |
| 2014-09-30 | -$9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $2.15M derived: sum of 2 quarters · filed 2015-11-05 | -$3.44M 10-Q · filed 2015-11-05 | -$13.04M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $12.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $6.46M 10-Q · filed 2015-08-07 | -$3.14M derived: sum of 3 quarters · filed 2016-03-11 | |
| 2014-03-31 | -$5.59M 10-Q · filed 2015-05-14 | -$15.19M derived: sum of 2 quarters · filed 2016-03-11 | ||
| 2013-12-31 | -$9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$25.33M 10-K · filed 2016-03-11 | ||
| 2013-09-30 | -$15.73M 10-Q · filed 2014-11-12 | |||
| 2012-12-31 | -$18.40M 10-K · filed 2015-03-18 |